米托蒽醌与阿霉素治疗晚期乳腺癌的随机交叉试验 - Suppr

Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.

作者信息

Neidhart J A, Gochnour D, Roach R W, Steinberg J A, Young D

出版信息

Cancer Treat Rev. 1983 Dec;10 Suppl B:41-6. doi: 10.1016/0305-7372(83)90021-x.

DOI:10.1016/0305-7372(83)90021-x

PMID:6362877

Abstract

摘要

相似文献

Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.

Cancer Treat Rev. 1983 Dec;10 Suppl B:41-6. doi: 10.1016/0305-7372(83)90021-x.

Mitoxantrone (novantrone): a review of experimental and early clinical studies.

Cancer Treat Rev. 1983 Jun;10(2):103-15. doi: 10.1016/0305-7372(83)90008-7.

Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.

Cancer Treat Rev. 1983 Dec;10 Suppl B:47-52. doi: 10.1016/0305-7372(83)90022-1.

A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).

Invest New Drugs. 1985;3(2):149-52. doi: 10.1007/BF00174162.

A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer.

Invest New Drugs. 1985;3(2):153-61. doi: 10.1007/BF00174163.

A comparison of mitoxantrone and doxorubicin in breast cancer.

J Clin Oncol. 1986 May;4(5):672-7. doi: 10.1200/JCO.1986.4.5.672.

Mitoxantrone--a critique.

Cancer Treat Rev. 1983 Dec;10 Suppl B:77-9. doi: 10.1016/0305-7372(83)90028-2.

Mitoxantrone in acute lymphoblastic leukemia.

Cancer Treat Rev. 1983 Dec;10 Suppl B:65-8. doi: 10.1016/0305-7372(83)90025-7.

Clinical safety and tolerance of mitoxantrone (Novantrone).

Cancer Treat Rev. 1983 Dec;10 Suppl B:29-36. doi: 10.1016/0305-7372(83)90019-1.

Mitoxantrone: a replacement for doxorubicin?

Drug Intell Clin Pharm. 1984 Jun;18(6):479-80. doi: 10.1177/106002808401800604.

引用本文的文献

Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group study.

Invest New Drugs. 1994;12(2):129-32. doi: 10.1007/BF00874442.

First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.

Invest New Drugs. 1985;3(2):167-71. doi: 10.1007/BF00174165.

Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.

Invest New Drugs. 1985;3(2):139-48. doi: 10.1007/BF00174161.

Mitoxantrone as a first-line treatment of advanced breast cancer.

Invest New Drugs. 1985;3(2):133-7. doi: 10.1007/BF00174160.

Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity.

Invest New Drugs. 1985;3(2):173-7. doi: 10.1007/BF00174166.

The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.

Am J Pathol. 1987 Jul;128(1):121-30.

Human central nervous system and plasma pharmacology of mitoxantrone.

J Neurooncol. 1988;6(1):75-83. doi: 10.1007/BF00163544.

Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II study.

Invest New Drugs. 1990 May;8(2):207-10. doi: 10.1007/BF00177262.

A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck.

Invest New Drugs. 1990 Feb;8(1):109-11. doi: 10.1007/BF00216935.

The effects of doxorubicin and mitoxantrone on wound healing.

Cancer Chemother Pharmacol. 1991;29(2):141-4. doi: 10.1007/BF00687324.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献